Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS Relapse

by Peter M. Ellis, Anand Swaminath, Gregory R. Pond
Published 2021-07-01

A population-based analysis of spirometry use and the prevalence of chronic obstructive pulmonary disease in lung cancer

by Sophie Corriveau, Gregory R. Pond, Grace H. Tang, John R. Goffin
Published 2021-01-01

Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare system.

by John R Goffin, Sophie Corriveau, Grace H Tang, Gregory R Pond
Published 2021-01-01

Advancing Academic Cancer Clinical Trials Recruitment in Canada

by Rebecca Y. Xu, Diana Kato, Gregory R. Pond, Stephen Sundquist, James Schoales, Saher Lalani, Janet E. Dancey
Published 2021-07-01

Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG...

by Christina L. Addison, Gregory R. Pond, Brandy Cochrane, Huijun Zhao, Stephen K. Chia, Mark N. Levine, Mark Clemons
Published 2015-06-01

Evaluating the Feasibility of Performing Window of Opportunity Trials in Breast Cancer

by Angel Arnaout, Susan Robertson, Iryna Kuchuk, Demetrios Simos, Gregory R. Pond, Christina L. Addison, Mehrzad Namazi, Mark Clemons
Published 2015-01-01

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey

by Mashari AlZahrani, Mark Clemons, Lisa Vandermeer, Marta Sienkiewicz, Arif Ali Awan, Brian Hutton, Gregory R. Pond, Terry L. Ng
Published 2021-02-01

Claudin-Low Breast Cancer; Clinical & Pathological Characteristics.

by Kay Dias, Anna Dvorkin-Gheva, Robin M Hallett, Ying Wu, John Hassell, Gregory R Pond, Mark Levine, Tim Whelan, Anita L Bane
Published 2017-01-01

Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

by Sarah Abou Alaiwi, Amin H Nassar, Pier Vitale Nuzzo, Ronan Flippot, Bradley A McGregor, Lauren C Harshman, Gregory R Pond, Catherine Curran, Kerry L Kilbridge, Xiao X Wei, Toni Choueiri
Published 2020-06-01

Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population

by John R. Goffin, Gregory R. Pond, Serge Puksa, Alain Tremblay, Michael Johnston, Glen Goss, Garth Nicholas, Simon Martel, Rick Bhatia, Geoffrey Liu, Heidi Schmidt, Sukhinder Atkar-Khattra, Annette McWilliams, Ming-Sound Tsao, Martin C. Tammemagi, Stephen Lam
Published 2020-11-01

Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT Restaging

by Wei Liu, MD, Katherine Zukotynski, MD, PhD, FRCPC, Louise Emmett, MD, FRACP, Hans T. Chung, MD, FRCPC, Peter Chung, MD, FRCPC, Robert Wolfson, MD, FRCPC, Irina Rachinsky, MD, MSc, FRCPC, Anil Kapoor, MD, FRCSC, Ur Metser, MD, FRCPC, Andrew Loblaw, MD, MSc, FRCPC, Gerard Morton, MB, FRCPC, Tracy Sexton, MD, PhD, FRCPC, Michael Lock, MD, FRCPC, Joelle Helou, MD, MSc, Alejandro Berlin, MD, MSc, Colm Boylan, MB, FRCPC, Susan Archer, BSc, Gregory R. Pond, PhD, PStat, Glenn Bauman, MD, FRCPC
Published 2021-01-01